Ovarian squamous cell carcinoma
MONDO:0003494A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor. The prognosis is poor.
Also known as: ovarian squamous cell cancer, ovarian squamous cell carcinoma, ovary squamous cell carcinoma
2854 clinical trials for this condition and its sub-types, 2 tagged with Ovarian squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare ovarian cancer: immunotherapy drug tested in small trial
Disease control OngoingThis study tests the drug pembrolizumab in 21 women with a rare and advanced form of ovarian cancer called squamous cell carcinoma. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants receive the drug intravenously, and the study tracks how …
Phase 2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC